AAAAAA

   
Results: 1-5 |
Results: 5
DISCRIMINANT VALIDITY OF THE SCL-90 DIMENSIONS OF ANXIETY AND DEPRESSION
Authors: MORGAN CD WIEDERMAN MW MAGNUS RD
Citation: Cd. Morgan et al., DISCRIMINANT VALIDITY OF THE SCL-90 DIMENSIONS OF ANXIETY AND DEPRESSION, Assessment, 5(2), 1998, pp. 197-201
SEROTONIN SYNDROME INDUCED BY VENLAFAXINE AND FLUOXETINE - A CASE-STUDY IN POLYPHARMACY AND POTENTIAL PHARMACODYNAMIC AND PHARMACOKINETIC MECHANISMS
Authors: BHATARA VS MAGNUS RD PAUL KL PRESKORN SH
Citation: Vs. Bhatara et al., SEROTONIN SYNDROME INDUCED BY VENLAFAXINE AND FLUOXETINE - A CASE-STUDY IN POLYPHARMACY AND POTENTIAL PHARMACODYNAMIC AND PHARMACOKINETIC MECHANISMS, The Annals of pharmacotherapy, 32(4), 1998, pp. 432-436
AN OPEN-LABEL PHARMACOKINETIC TRIAL OF NEFAZODONE IN DEPRESSED CHILDREN AND ADOLESCENTS
Authors: MAGNUS RD FINDLING R PRESKORN SH FRIESEN S MARCUS R MARATHE P DAMICO F
Citation: Rd. Magnus et al., AN OPEN-LABEL PHARMACOKINETIC TRIAL OF NEFAZODONE IN DEPRESSED CHILDREN AND ADOLESCENTS, Psychopharmacology bulletin, 33(3), 1997, pp. 550-550
INHIBITION OF HEPATIC P-450 ISOENZYMES BY SEROTONIN SELECTIVE REUPTAKE INHIBITORS - IN-VITRO AND IN-VIVO FINDINGS AND THEIR IMPLICATIONS FOR PATIENT-CARE
Authors: PRESKORN SH MAGNUS RD
Citation: Sh. Preskorn et Rd. Magnus, INHIBITION OF HEPATIC P-450 ISOENZYMES BY SEROTONIN SELECTIVE REUPTAKE INHIBITORS - IN-VITRO AND IN-VIVO FINDINGS AND THEIR IMPLICATIONS FOR PATIENT-CARE, Psychopharmacology bulletin, 30(2), 1994, pp. 251-259
INHIBITION OF HEPATIC P-450 ISOENZYMES BY SEROTONIN SELECTIVE REUPTAKE INHIBITORS - IN-VITRO AND IN-VIVO FINDINGS AND THEIR IMPLICATIONS FOR PATIENT-CARE
Authors: PRESKORN SH MAGNUS RD
Citation: Sh. Preskorn et Rd. Magnus, INHIBITION OF HEPATIC P-450 ISOENZYMES BY SEROTONIN SELECTIVE REUPTAKE INHIBITORS - IN-VITRO AND IN-VIVO FINDINGS AND THEIR IMPLICATIONS FOR PATIENT-CARE, Psychopharmacology bulletin, 30(2), 1994, pp. 251-259
Risultati: 1-5 |